SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
TetraLogic Pharmaceuticals' Smac Mimetic Birinapant Selected for Oral Presentation at the 17th Japanese Foundation for Cancer Research – International Symposium on Cancer Chemotherapy